Administration of Ampicillin Elevates Hepatic Primary Bile Acid Synthesis through Suppression of Ileal Fibroblast Growth Factor 15 Expression
Abstract
Administration of the antibacterial drug ampicillin (ABPC) significantly increased hepatic bile acid concentrations. In the present study, we investigated the mechanisms for the elevation of bile acid levels in ABPC-treated mice. Hepatic microsomal cholesterol 7alpha-hydroxylation and CYP7A1 mRNA level were increased 2.0-fold in ABPC-treated mice despite higher bile acid levels in the liver and small intestinal lumen. A significant change in hepatic small heterodimer partner (SHP) mRNA level was not observed in ABPC-treated mice, whereas a marked decrease in ileal fibroblast growth factor 15 (FGF15) mRNA level was observed (3% of vehicle-treated mice). These phenomena were also observed in mice cotreated with bacitracin/streptomycin/neomycin, which are barely absorbed from the intestine. Primary bile acid contents in the small intestinal lumen were increased in ABPC-treated mice, whereas secondary bile acid, deoxycholic acid (DCA), contents were reduced to below detection limits (<0.01 micromol). In ABPC-treated mice, cotreatment with tauroDCA reversed reductions in ileal FGF15 mRNA level. Ileal SHP mRNA level was, however, not decreased in ABPC-treated mice. ABPC administration to farnesoid X receptor (Fxr)-null mice also decreased ileal FGF15 mRNA levels and secondary bile acid content in the small intestinal lumen. These results suggest that ABPC administration elevates hepatic primary bile acid synthesis, at least in part, through suppression of ileal FGF15 expression.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The gut microbiota regulates secondary bile acid metabolism and bile acid synthesis in the liver by alleviating the enterohepatic FXR-FGF15 axis.
“Furthermore, many studies have shown that the gut microbiota regulates secondary BA metabolism and BA synthesis in the liver by alleviating the enterohepatic FXR-fibroblast growth factor 15 (FGF15) axis (6, 9).”
Cites
Bile salt biotransformations by human intestinal bacteria
Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829 · see citing works
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714 · see citing works
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274 · see citing works
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
Goodwin, B., Jones, S. A., Price, R. R., Watson, M. A., McKee, D. D., Moore, L. B., Galardi, C., Wilson, J. G., Lewis, M. C., Roth, M. E., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00051-4 · Cited by 1,940 · see citing works
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.001 · Cited by 1,865 · see citing works
Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
Sinal, C. J., Tohkin, M., Miyata, M., Ward, J. M., Lambert, G., & Gonzalez, F. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00062-3 · Cited by 1,819 · see citing works
Self-citationEndogenous Bile Acids Are Ligands for the Nuclear Receptor FXR/BAR
Wang, H., Chen, J., Hollister, K., Sowers, L. C., & Forman, B. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80348-2 · Cited by 1,636 · see citing works
Bile acids: regulation of synthesis
Chiang, J. Y. L. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900010-jlr200 · Cited by 1,567 · see citing works
Molecular Basis for Feedback Regulation of Bile Acid Synthesis by Nuclear Receptors
Lu, T. T., Makishima, M., Repa, J. J., Schoonjans, K., Kerr, T. A., Auwerx, J., & Mangelsdorf, D. J. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00050-2 · Cited by 1,487 · see citing works
Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c
渡辺, 光., Houten, S. M., Wang, L., Moschetta, A., Mangelsdorf, D. J., Heyman, R. A., Moore, D. D., & Auwerx, J. H. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21025 · Cited by 1,398 · see citing works
Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice
Zhang, Y., Lee, F. Y., Barrera, G., Lee, H., Vales, C., Gonzalez, F. J., Willson, T. M., & Edwards, P. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506982103 · Cited by 951 · see citing works
Farnesoid X receptor is essential for normal glucose homeostasis
Ma, K. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25604 · Cited by 883 · see citing works
Holt, J. A., Luo, G., Billin, A. N., Bisi, J., McNeill, Y. Y., Kozarsky, K., Donahee, M. H., Wang, D. Y., Mansfield, T. A., Kliewer, S. A., et al. (2003) · Genes & Development · doi:10.1101/gad.1083503 · Cited by 698 · see citing works
Bile acids as regulatory molecules
Hylemon, P. B., Zhou, H., Pandak, W. M., Ren, S., Gil, G., & Dent, P. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900007-jlr200 · Cited by 694 · see citing works
Fu, L., John, L. M., Adams, S. H., Yu, X. X., Tomlinson, E., Renz, M. E., Williams, P. M., Soriano, R. H., Corpuz, R. T., Moffat, B., et al. (2004) · Endocrinology · doi:10.1210/en.2003-1671 · Cited by 580 · see citing works
Tomlinson, E., Fu, L., John, L., Hultgren, B., Huang, X., Renz, M., Stephan, J. P., Tsai, S. P., Powell-Braxton, L., French, D., et al. (2002) · Endocrinology · doi:10.1210/endo.143.5.8850 · Cited by 576 · see citing works
Kim, I., Ahn, S.-H., Inagaki, T., Choi, M., Ito, S., Guo, G. L., Kliewer, S., & Gonzalez, F. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700330-jlr200 · Cited by 575 · see citing works
Antibiotic-associated diarrhoea
Beaugerie, L., & Petit, J. (2004) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2003.10.002 · Cited by 235 · see citing works
Fibroblast Growth Factor-19, a Novel Factor That Inhibits Hepatic Fatty Acid Synthesis
Bhatnagar, S., Damron, H. A., & Hillgartner, F. B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808818200 · Cited by 209 · see citing works
Pandak, W. M., Li, Y. C., Chiang, J. Y. L., Studer, E. J., Gurley, E. C., Heuman, D. M., Vlahcevic, Z. R., & Hylemon, P. B. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)67810-5 · Cited by 193 · see citing works
Kitahara, M., Takamine, F., Imamura, T., & Benno, Y. (2001) · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · doi:10.1099/00207713-51-1-39 · Cited by 189 · see citing works
Bile acids and signal transduction: Role in glucose homeostasis
Nguyen, A., & Bouscarel, B. E. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.06.014 · Cited by 165 · see citing works
Protective Role of Hydroxysteroid Sulfotransferase in Lithocholic Acid-induced Liver Toxicity
Kitada, H., Miyata, M., Nakamura, T., Tozawa, A., Honma, W., Shimada, M., Nagata, K., Sinal, C. J., Guo, G. L., Gonzalez, F. J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210634200 · Cited by 151 · see citing works
Self-citationBerr, F., Kullak‐Ublick, G., Paumgartner, G., Münzing, W., & Hylemon, P. (1996) · Gastroenterology · doi:10.1016/s0016-5085(96)70024-0 · Cited by 149 · see citing works
Miao, J., Xiao, Z., Kanamaluru, D., Min, G., Yau, P. M., Veenstra, T. D., Ellis, E. C. S., Strom, S., Suino-Powell, K. M., Xu, H. E., et al. (2009) · Genes & Development · doi:10.1101/gad.1773909 · Cited by 126 · see citing works
FGF15/FGFR4 Integrates Growth Factor Signaling with Hepatic Bile Acid Metabolism and Insulin Action
Shin, D.-J., & Osborne, T. F. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808747200 · Cited by 111 · see citing works
Regulation of cholesterol and bile acid homoeostasis in bile-obstructed rats
Dueland, S., Reichen, J., Everson, G. T., & Davis, R. A. (1991) · Biochemical Journal · doi:10.1042/bj2800373 · Cited by 109 · see citing works
Bile Acids, Diarrhea, and Antibiotics: Data, Speculation, and a Unifying Hypothesis
Hofmann, A. F. (1977) · The Journal of Infectious Diseases · doi:10.1093/infdis/135.supplement.s126 · Cited by 74 · see citing works
Gutierrez, A., Ratliff, E. P., Andres, A. M., Huang, X., McKeehan, W. L., & Davis, R. A. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000195793.73118.b4 · Cited by 59 · see citing works
Lithocholic acid induction of the FGF19 promoter in intestinal cells is mediated by PXR
Wistuba, W. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i31.4230 · Cited by 57 · see citing works
Hepatotoxicity Due to Antibiotics
Polson, J. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.06.009 · Cited by 57 · see citing works
[46] Reversed-phase high-performance liquid chromatography assay of cholesterol 7α-hydroxylase
Chiang, J. Y. L. (1991) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(91)06117-l · Cited by 55 · see citing works
A role for FXR and human FGF-19 in the repression of paraoxonase-1 gene expression by bile acids
Shih, D. M., Kast-Woelbern, H. R., Wong, J., Xia, Y.-R., Edwards, P. A., & Lusis, A. J. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500378-jlr200 · Cited by 48 · see citing works
Kinouchi, T., Kataoka, K., Miyanishi, K., Akimoto, S., & Ohnishi, Y. (1993) · Carcinogenesis · doi:10.1093/carcin/14.5.869 · Cited by 47 · see citing works
Carulli, N., de Leòn, M. P., Loria, P., Iori, R., Rosi, A., & Romani, M. (1981) · Gastroenterology · doi:10.1016/0016-5085(81)90608-9 · Cited by 39 · see citing works
Miyata, M., Tozawa, A., Otsuka, H., Nakamura, T., Nagata, K., Gonzalez, F. J., & Yamazoe, Y. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.076158 · Cited by 37 · see citing works
Self-citationRegulation of bile acid synthesis under reconstructed enterohepatic circulation in rats
Nagano, M., Kuroki, S., Mizuta, A., Furukawa, M., Noshiro, M., Chijiiwa, K., & Tanaka, M. (2004) · Steroids · doi:10.1016/j.steroids.2004.07.004 · Cited by 29 · see citing works
Miyata, M., Watase, H., Hori, W., Shimada, M., Nagata, K., Gonzalez, F. J., & Yamazoe, Y. (2006) · Xenobiotica · doi:10.1080/00498250600776827 · Cited by 25 · see citing works
Self-citationIntestinal Microbes in Health and Disease
Hecht, G. A. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.03.057 · Cited by 6 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Bile acid signaling in metabolic disease and drug therapy
Li, T., & Chiang, J. Y. L. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008201 · Cited by 935 · see citing works
Chen, M.-L., Yi, L., Zhang, Y., Zhou, X., Ran, L., Yang, J., Zhu, J.-D., Zhang, Q.-Y., & Mi, M.-T. (2016) · mBio · doi:10.1128/mbio.02210-15 · Cited by 754 · see citing works
“Furthermore, many studies have shown that the gut microbiota regulates secondary BA metabolism and BA synthesis in the liver by alleviating the enterohepatic FXR-fibroblast growth factor 15 (FGF15) axis (6, 9).”
BackgroundBile Acid-Activated Receptors, Intestinal Microbiota, and the Treatment of Metabolic Disorders
Fiorucci, S., & Distrutti, E. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.09.001 · Cited by 539 · see citing works
Bile acid metabolism and signaling, the microbiota, and metabolic disease
Cai, J., Rimal, B., Jiang, C., Chiang, J. Y. L., & Patterson, A. D. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108238 · Cited by 513 · see citing works
Role of the Microbiome in Energy Regulation and Metabolism
Nieuwdorp, M., Gilijamse, P. W., Pai, N., & Kaplan, L. M. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.02.008 · Cited by 421 · see citing works
An Intestinal Microbiota–Farnesoid X Receptor Axis Modulates Metabolic Disease
Gonzalez, F. J., Jiang, C., & Patterson, A. D. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.08.057 · Cited by 377 · see citing works
The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus
Kootte, R. S., Vrieze, A., Holleman, F., Dallinga‐Thie, G. M., Zoetendal, E. G., de Vos, W. M., Groen, A. K., Hoekstra, J. B. L., Stroes, E. S. G., & Nieuwdorp, M. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01483.x · Cited by 348 · see citing works
Oral treatment with Eubacterium hallii improves insulin sensitivity in db/db mice
Udayappan, S. D., Mannerås-Holm, L., Chaplin, A. M. L., Belzer, C., Herrema, H., Dallinga‐Thie, G. M., Duncan, S. H., Stroes, E. S. G., Groen, A. K., Flint, H. J., et al. (2016) · npj Biofilms and Microbiomes · doi:10.1038/npjbiofilms.2016.9 · Cited by 264 · see citing works
Joyce, S. A., & Gahan, C. G. M. (2016) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-041715-033159 · Cited by 241 · see citing works
Impact of Gut Microbiota and Microbiota-Related Metabolites on Hyperlipidemia
Jia, X., Xu, W., Zhang, L., Li, X., Wang, R., & Wu, S. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.634780 · Cited by 233 · see citing works
Qi, Y., Jiang, C., Cheng, J., Krausz, K. W., Li, T., Ferrell, J. M., Gonzalez, F. J., & Chiang, J. Y. L. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.04.008 · Cited by 205 · see citing works
van Midwoud, P. M., Merema, M. T., Verpoorte, E., & Groothuis, G. M. M. (2010) · Lab on a Chip · doi:10.1039/c0lc00043d · Cited by 203 · see citing works
Review: Mechanisms of How the Intestinal Microbiota Alters the Effects of Drugs and Bile Acids
Klaassen, C. D., & Cui, J. Y. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.065698 · Cited by 208 · see citing works
Implication of gut microbiota metabolites in cardiovascular and metabolic diseases
Brial, F., Lay, A. L., Dumas, M., & Gauguier, D. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2901-1 · Cited by 197 · see citing works
Joyce, S. A., Kamil, A., Fleige, L. E., & Gahan, C. G. M. (2019) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00171 · Cited by 203 · see citing works
Molecular basis of bile acid-FXR-FGF15/19 signaling axis
Katafuchi, T., & Makishima, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116046 · Cited by 193 · see citing works
Jones, M. L., Tomaro-Duchesneau, C., Martoni, C. J., & Prakash, S. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.758706 · Cited by 190 · see citing works
The Role of the Gut Microbiota in Lipid and Lipoprotein Metabolism
Yu, Y., Raka, F., & Adeli, K. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122227 · Cited by 158 · see citing works
The human microbiome and bile acid metabolism: Dysbiosis, dysmetabolism, disease and intervention
Jones, M. L., Martoni, C. J., Ganopolsky, J. G., Labbé, A., & Prakash, S. (2014) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2014.880420 · Cited by 150 · see citing works
Cross-talk between bile acids and intestinal microbiota in host metabolism and health
Nie, Y., Hu, J. P., & Yan, X. (2015) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1400327 · Cited by 128 · see citing works
The gut microbiome in cardio-metabolic health
Hansen, T. H., Gøbel, R. J., Hansen, T. F., & Pedersen, O. B. (2015) · Genome Medicine · doi:10.1186/s13073-015-0157-z · Cited by 124 · see citing works
Fibroblast Growth Factor 15/19: From Basic Functions to Therapeutic Perspectives
Somm, E., & Jornayvaz, F. R. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00134 · Cited by 118 · see citing works
Gut microbiota inhibit Asbt-dependent intestinal bile acid reabsorption via Gata4
Out, C., Patankar, J. V., Doktorova, M., Boesjes, M., Bos, T., de Boer, S., Havinga, R., Wolters, H., Boverhof, R., van Dijk, T. H., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.04.030 · Cited by 117 · see citing works
Muricholic bile acids are potent regulators of bile acid synthesis via a positive feedback mechanism
Hu, X., Bonde, Y., Eggertsen, G., & Rudling, M. J. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12140 · Cited by 103 · see citing works
Udayappan, S. D., Hartstra, A. V., Dallinga‐Thie, G. M., & Nieuwdorp, M. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12293 · Cited by 101 · see citing works
Pereira-Fantini, P. M., Lapthorne, S., Joyce, S. A., Dellios, N. L., Wilson, G., Fouhy, F., Thomas, S., Scurr, M., Hill, C., Gahan, C. G. M., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.06.025 · Cited by 91 · see citing works
Bile acid-based therapies for non-alcoholic steatohepatitis and alcoholic liver disease
Li, T., & Chiang, J. Y. L. (2020) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn.2019.09.03 · Cited by 86 · see citing works
Bile acids-gut microbiota crosstalk contributes to the improvement of type 2 diabetes mellitus
Gao, R., Meng, X., Xue, Y., Mao, M., Liu, Y., Tian, X., Sui, B., Li, X., & Zhang, P. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1027212 · Cited by 84 · see citing works
Miyata, M., Sakaida, Y., Matsuzawa, H., Yoshinari, K., & Yamazoe, Y. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.1885 · Cited by 77 · see citing works
Self-citationParenteral Nutrition-Associated Liver Disease: The Role of the Gut Microbiota
Cahová, M., Brátová, M., & Wohl, P. (2017) · Nutrients · doi:10.3390/nu9090987 · Cited by 71 · see citing works
Muricholic Acids Inhibit Clostridium difficile Spore Germination and Growth
Francis, M. B., Allen, C. A., & Sorg, J. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073653 · Cited by 68 · see citing works
Kuribayashi, H., Miyata, M., Yamakawa, H., Yoshinari, K., & Yamazoe, Y. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.09.048 · Cited by 68 · see citing works
Self-citationJones, S. A. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0887-1_11 · Cited by 68 · see citing works
Mechanisms of enterohepatic fibroblast growth factor 15/19 signaling in health and disease
Jahn, D., Rau, M., Hermanns, H. M., & Geier, A. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.07.016 · Cited by 62 · see citing works
Somm, E., Henry, H., Bruce, S. J., Aeby, S., Rosikiewicz, M., Sykiotis, G. P., Asrih, M., Jornayvaz, F. R., Denechaud, P., Albrecht, U., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.91809 · Cited by 57 · see citing works
Rune, I., Rolin, B. C., Larsen, C. S., Nielsen, D. S., Kanter, J. E., Bornfeldt, K., Lykkesfeldt, J., Buschard, K., Kirk, R. K., Christoffersen, B. Ø., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146439 · Cited by 56 · see citing works
Rodríguez-Morató, J., & Matthan, N. R. (2020) · Current Atherosclerosis Reports · doi:10.1007/s11883-020-00863-7 · Cited by 53 · see citing works
Does the Gut Microbiota Contribute to Obesity? Going beyond the Gut Feeling
Aguirre, M., & Venema, K. (2015) · Microorganisms · doi:10.3390/microorganisms3020213 · Cited by 50 · see citing works
Miyata, M., Yamakawa, H., Hamatsu, M., Kuribayashi, H., Takamatsu, Y., & Yamazoe, Y. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.171736 · Cited by 50 · see citing works
Self-citationNew Insights into Bile Acid Malabsorption
Johnston, I. M., Nolan, J., Pattni, S. S., & Walters, J. R. F. (2011) · Current Gastroenterology Reports · doi:10.1007/s11894-011-0219-3 · Cited by 46 · see citing works
Bile acid homeostasis in gastrointestinal and metabolic complications of cystic fibrosis
van de Peppel, I. P., Bodewes, F. A. J. A., Verkade, H. J., & Jonker, J. W. (2018) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2018.08.009 · Cited by 42 · see citing works
Hasuike, Y., Endo, T., Koroyasu, M., Matsui, M., Mori, C., Yamadera, M., Fujimura, H., & Sakoda, S. (2019) · Medical Hypotheses · doi:10.1016/j.mehy.2019.109436 · Cited by 42 · see citing works
Involvement of multiple elements in FXR-mediated transcriptional activation of FGF19
Miyata, M., Hata, T., Yamakawa, H., Kagawa, T., Yoshinari, K., & Yamazoe, Y. (2012) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2012.04.008 · Cited by 38 · see citing works
Self-citationGut Microbiota and Cardiovascular Diseases
Anselmi, G., Gagliardi, L., Egidi, G., Leone, S., Gasbarrini, A., Miggiano, G. A. D., & Galiuto, L. (2020) · Cardiology in Review · doi:10.1097/crd.0000000000000327 · Cited by 37 · see citing works
The gut microbiota of nonalcoholic fatty liver disease: current methods and their interpretation
van Best, N., Jansen, P. L. M., & Rensen, S. S. (2015) · Hepatology International · doi:10.1007/s12072-015-9640-2 · Cited by 36 · see citing works
SREBP-2 negatively regulates FXR-dependent transcription of FGF19 in human intestinal cells
Miyata, M., Hata, T., Yamazoe, Y., & Yoshinari, K. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.11.126 · Cited by 35 · see citing works
Self-citationAssociation of gut dysbiosis with intestinal metabolites in response to antibiotic treatment
Khan, T. J., Hasan, M. N., Azhar, E. I., & Yasir, M. (2019) · Human Microbiome Journal · doi:10.1016/j.humic.2018.11.004 · Cited by 26 · see citing works
β-Klotho deficiency shifts the gut-liver bile acid axis and induces hepatic alterations in mice
Somm, E., Henry, H., Bruce, S. J., Bonnet, N., Montandon, S. A., Niederländer, N. J., Messina, A., Aeby, S., Rosikiewicz, M., Fajas, L., et al. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00182.2018 · Cited by 25 · see citing works
Antibiotic-induced Elevations of Plasma Bile Acids in Rats Independent of Bsep Inhibition
Li, Y., Hafey, M. J., Duong, H., Evers, R., Cheon, K., Holder, D., Galijatovic-Idrizbegovic, A., Sistare, F. D., & Glaab, W. E. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx015 · Cited by 24 · see citing works
Wang, N., Wang, J., Zhang, T., Huang, L., Yan, W., Lu, L., Jia, J., Tao, Y., Cai, W., & Wang, Y. (2020) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2020.06.035 · Cited by 19 · see citing works
vMAlteration of bile acid metabolism in pseudo germ-free rats
Bhowmik, S. K., An, J. H., Lee, S. H., & Jung, B. H. (2012) · Archives of Pharmacal Research · doi:10.1007/s12272-012-1114-7 · Cited by 16 · see citing works
Impact of cholecystectomy on the gut-liver axis and metabolic disorders
Raposo, M. A., Oliveira, E., Santos, A., Guadagnini, D., Mourabit, H. E., Housset, C., Lemoinne, S., & Saad, M. J. A. (2024) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2024.102370 · Cited by 14 · see citing works
Miyata, M., Tanaka, T., Takahashi, K., Funaki, A., & Sugiura, Y. (2021) · Amino Acids · doi:10.1007/s00726-021-03068-7 · Cited by 14 · see citing works
Self-citationThe Biliary System, Second Edition
Wang, D. Q. ‐., Neuschwander‐Tetri, B. A., & Portincasa, P. (2016) · Colloquium Series on Integrated Systems Physiology From Molecule to Function · doi:10.4199/c00147ed2v01y201611isp071 · Cited by 11 · see citing works
Role of sirtuins in obesity and osteoporosis: molecular mechanisms and therapeutic targets
Du, Y., Huo, Y., Yang, Y., Lin, P., Liu, W., Wang, Z., Zeng, W., Li, J., Liang, Z., Yuan, C., et al. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-024-02025-7 · Cited by 10 · see citing works
Host–Microbiome Interaction in the Intensive Care Unit
Neag, M. A., Mitre, A. O., Pomana, I. G., Velescu, M. A., Militaru, C. F., Nagy, G. A., & Melincovici, C. S. (2025) · Diseases · doi:10.3390/diseases13080250 · Cited by 12 · see citing works
Carson, M. D., Warner, A. J., Geiser, V. L., Hathaway‐Schrader, J. D., Alekseyenko, A. V., Marshall, J. L., Westwater, C., & Novince, C. M. (2023) · American Journal Of Pathology · doi:10.1016/j.ajpath.2023.02.014 · Cited by 10 · see citing works
Wang, D. Q. ‐., Neuschwander‐Tetri, B. A., & Portincasa, P. (2012) · Colloquium Series on Integrated Systems Physiology From Molecule to Function · doi:10.4199/c00051ed1v01y201202isp033 · Cited by 8 · see citing works
Miyata, M., Hayashi, K., Yamakawa, H., Yamazoe, Y., & Yoshinari, K. (2014) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b14-00640 · Cited by 8 · see citing works
Self-citationRudling, M., & Bonde, Y. (2015) · Digestive Diseases · doi:10.1159/000371690 · Cited by 6 · see citing works
Chen, J., Liu, Y., Huang, Y., Tong, A., Liu, B., & Zeng, F. (2021) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.202100108 · Cited by 5 · see citing works
Cuevas‐Sierra, A., Higuera‐Gómez, A., de Cuevillas, B., Amigó, N., Martínez‐Urbistondo, M., Castejón, R., Vargas, J. A., & Martinez, J. A. (2026) · Scientific Reports · doi:10.1038/s41598-026-36024-0 · Cited by 2 · see citing works
Ларін, О. С., Tkach, S. M., Тимошенко, А. С., & Кузенко, Ю. Г. (2016) · Clinical endocrinology and endocrine surgery · doi:10.24026/1818-1384.2(54).2016.75861 · Cited by 2 · see citing works
Vajro, P., & Mandato, C. (2018) · MDPI eBooks · doi:10.3390/books978-3-03842-924-1 · Cited by 2 · see citing works
Dayangaç, A., Işık, B., Bahşi, M., Aktaş, T., Akyildiz, G., & Yılmaz, Ö. (2015) · International Journal of Scientific and Technological Research
Cox, A. J., West, N. P., & Cripps, A. W. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch17
Role of Enterobacteria-mediated Bile Acid Signaling in Lipid Homeostasis
Miyata, M. (2014) · Oleoscience · doi:10.5650/oleoscience.14.381
Self-citationOchi, T., Takeda, M., Asahara, T., Kurita, A., Ogata, Y., Suzuki, M., Takei, H., Nittono, H., Miyano, G., Koga, H., et al. (2025) · Pediatric Surgery International · doi:10.1007/s00383-025-06239-9
Unconventional mechanisms of resveratrol in atherosclerosis prevention and management
Chaarani, N., Mroweh, R., Moghnieh, R., Chahine, M. K., Zaiter, H., Abdulaal, S.-Y., OBEID, N., Tlais, M., Raheb, J., Farhat, H., et al. (2026) · World Journal of Experimental Medicine · doi:10.5493/wjem.v16.i1.116771
Gatsura, V. Y., Deryagina, L. E., Pyatibrat, A. O., Reiniuk, V. L., Козлов, В. К., Pyatibrat, E. D., Стельмах, В. В., & Romanov, V. V. (2026) · Экология человека · doi:10.17816/humeco701966
Hsu, S., Chua, H., Liou, B., Cheng, Y., Lin, C.-R., Chen, Y., Yang, T., Wu, S., Tsuei, D., Chen, H., et al. (2026) · The Journal of Pathology · doi:10.1002/path.70101
- Authors
- Miyata, M., Takamatsu, Y., Kuribayashi, H., & Yamazoe, Y.
- Affiliations
- Tohoku University (JP)
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 2009-12
- Volume
- 331
- Issue
- 3
- Pages
- 1079-1085
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W2055432113
- Cited by
- 72
- References
- 39
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 3 · 2020: 4 · 2019: 4 · 2018: 5 · 2017: 3 · 2016: 8 · 2015: 10 · 2014: 8 · 2013: 5 · 2012: 5
- FWCI
- 1.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Pharmacology and Experimental Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
- Keywords
- ampicillin, FGF15, ileum, small heterodimer partner, CYP7A1, farnesoid X receptor, deoxycholic acid, secondary bile acids
- MeSH terms
- Receptor, Farnesoid X-Activated, Ampicillin, Animals, Anti-Bacterial Agents, Bile Acids and Salts, Cholesterol 7-alpha-Hydroxylase, Fibroblast Growth Factors, Ileum, Liver, Male, Mice, Inbred C57BL, Microsomes, Liver, Receptors, Cytoplasmic and Nuclear, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
